Emerging Market and Trends in Global Autoimmune Monoclonal Antibodies April.2017 | Page 6

Global Autoimmune Monoclonal Antibodies Market 7.4.2 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target 7.5 Key Trends in Monoclonal Antibodies Development 7.5.1 Targeted Therapies 7.6 Promising Monoclonal Antibodies in Pipeline 7.7 Heat Map of Safety and Efficacy for Pipeline and Marketed Monoclonal Antibodies 8.Strategic Analysis Buy this report at https://www.marketdataforecast.com/cart/buy-now/global-autoimmune- monoclonal-antibodies-1170 8.1 PESTLE analysis 8.1.1 Political 8.1.2 Economic 8.1.3 Social 8.1.4 Technological 8.1.5 Legal 8.1.6 Environmental 8.2 Porter’s Five analysis 8.2.1 Bargaining Power of Suppliers 8.2.2 Bargaining Power of Consumers 8.2.3 Threat of New Entrants 8.2.4 Threat of Substitute Products and Services 8.2.5 Competitive Rivalry within the Industry 9.Market Leaders' Analysis 9.1 GlaxoSmithKline plc (U.K.) 9.1.1 Overview 9.1.2 Product Analysis 9.1.3 Financial analysis 9.1.4 Recent Developments 9.1.5 SWOT analysis 9.1.6 Analyst View 9.2 AstraZeneca plc (U.K.) [phone] | www.marketdataforecast.com | [email protected]